Bath Salt Abuse: Neuropsychiatric Effects of Cathinone Derivatives

Psychosomatics

Volumn 52, Issue 6, 2011, Pages 593-594

  Goshgarian, Anne M ^a   Benford, Dawn M ^b   Caplan, Jason P ^b  

^a CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ST JOSEPH'S HOSPITAL AND MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; CANNABIS; CATHINONE; DESVENLAFAXINE; LYSERGIDE; METHAMPHETAMINE; ALKALOID; CENTRAL STIMULANT AGENT; INORGANIC SALT;

ADULT; ALCOHOL ABSTINENCE; ALCOHOL ABUSE; AUDITORY HALLUCINATION; BATH SALT ABUSE; CANNABIS ADDICTION; CASE REPORT; DEPRESSION; EMERGENCY WARD; HOSPITAL DISCHARGE; HUMAN; INSOMNIA; LETTER; MALE; OUTPATIENT CARE; PARANOIA; PATIENT REFERRAL; PSYCHOSIS; SUBSTANCE ABUSE;

ADULT; ALKALOIDS; CENTRAL NERVOUS SYSTEM STIMULANTS; HUMANS; MALE; PSYCHOSES, SUBSTANCE-INDUCED; SALTS;

EID: 84857413638     PISSN: 00333182     EISSN: 15457206     Source Type: Journal    
DOI: 10.1016/j.psym.2011.03.003     Document Type: Letter

References (4)

1. Volkow N.D. Message from the Director on "Bath Salts" - emerging and dangerous products. National Institute on Drug Abuse Accessed March 2, 2011. http://www.drugabuse.gov/about/welcome/MessageBathSalts211.html.
2. James D., Adams R.D., Spears R., et al. Clinical characteristics of mephedrone toxicity reported to the UK national poisons information service. Emerg Med J 2011, 28:686-689.
3. Schifano F., Albanese A., Fergus S., et al. Mephedrone (4-methylmethcathinone; 'meow meow'): chemical, pharmacologic, and clinical issues. Psychopharmacology 2011, 214:593-602.
4. Meyer M.R., Wilhelm J., Peters F.T., et al. Beta-keto amphetamines: studies on the metabolism of the designer drug mephedrone and toxicologic detection of mephedrone, butylone, and methylone in urine using gas chromatography-mass spectrometry. Anal Bioanal Chem 2010, 397:1225-1233.